相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Advanced glycation end-products disrupt human endothelial cells redox homeostasis: new insights into reactive oxygen species production
Anthony Dobi et al.
FREE RADICAL RESEARCH (2019)
NADPH Oxidase Hyperactivity Contributes to Cardiac Dysfunction and Apoptosis in Rats with Severe Experimental Pancreatitis through ROS-Mediated MAPK Signaling Pathway
Yi Wen et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Diabetes Mellitus and Its Cardiovascular Complications: New Insights into an Old Disease
Celestino Sardu et al.
JOURNAL OF DIABETES RESEARCH (2019)
Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target
Jing-Jie Peng et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Apigenin and its methylglyoxal-adduct inhibit advanced glycation end products-induced oxidative stress and inflammation in endothelial cells
Qian Zhou et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Advanced glycation end-products induce oxidative stress through the Sirt1/Nrf2 axis by interacting with the receptor of AGEsunder diabetic conditions
Xiao-Jun Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Estimation of global insulin use for type 2 diabetes, 2018-30: a microsimulation analysis
Sanjay Basu et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Association of antioxidant status and inflammatory markers with metabolic syndrome in Thais
Kanjana Suriyaprom et al.
JOURNAL OF HEALTH POPULATION AND NUTRITION (2019)
Novel pharmacological therapy in type 2 diabetes mellitus with established cardiovascular disease: Current evidence
Leonardo Pozo et al.
WORLD JOURNAL OF DIABETES (2019)
Purification and Characterization of the Soluble form of the Receptor for Advanced Glycation End-Products (sRAGE): A Novel Fast, Economical and Convenient Method
Varun Kumar et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2018)
Irisin Alleviates Advanced Glycation End Products-Induced Inflammation and Endothelial Dysfunction via Inhibiting ROS-NLRP3 Inflammasome Signaling
Xian Deng et al.
INFLAMMATION (2018)
Metabolic memory: Evolving concepts
Anoop Misra et al.
JOURNAL OF DIABETES (2018)
Angiogenesis impairment by the NADPH oxidase-triggered oxidative stress at the bone-implant interface: Critical mechanisms and therapeutic targets for implant failure under hyperglycemic conditions in diabetes
Xiao-Fan Hu et al.
ACTA BIOMATERIALIA (2018)
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity
Guanghong Jia et al.
CIRCULATION RESEARCH (2018)
Mortality Reduction in EMPA-REG OUTCOME Trial: Beyond the Antidiabetes Effect
Samy Suissa
DIABETES CARE (2018)
Cardiovascular biomarkers in clinical studies of type 2 diabetes
Maria P. A. Baldassarre et al.
DIABETES OBESITY & METABOLISM (2018)
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
N. H. Cho et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Methylglyoxal induced advanced glycation end products (AGE)/receptor for AGE (RAGE)-mediated angiogenic impairment in bone marrow-derived endothelial progenitor cells
Jeong-Hyeon Kim et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2018)
Advanced Glycation End Products Are Associated With Physical Activity and Physical Functioning in the Older Population
Hans Drenth et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2018)
Andrographolide Ameliorates Diabetic Cardiomyopathy in Mice by Blockage of Oxidative Damage and NF-κB-Mediated Inflammation
Ershun Liang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Ethanol-induced cardiomyocyte toxicity implicit autophagy and NFkB transcription factor
Jessica Maiuolo et al.
PHARMACOLOGICAL RESEARCH (2018)
AGEs, RAGEs and s-RAGE; friend or foe for cancer
Saheem Ahmad et al.
SEMINARS IN CANCER BIOLOGY (2018)
Diabetic macroangiopathy: Pathogenetic insights and novel therapeutic approaches with focus on high glucose-mediated vascular damage
Rosalinda Madonna et al.
VASCULAR PHARMACOLOGY (2018)
Acute vitamin C improves cardiac function, not exercise capacity, in adults with type 2 diabetes
Rebecca L. Scalzo et al.
DIABETOLOGY & METABOLIC SYNDROME (2018)
AGE/RAGE-Induced EMP Release via the NOX-Derived ROS Pathway
Ying-Hua Chen et al.
JOURNAL OF DIABETES RESEARCH (2018)
Soluble Fms-Like Tyrosine Kinase-1 Alters Cellular Metabolism and Mitochondrial Bioenergetics in Preeclampsia
Lissette C. Sanchez-Aranguren et al.
FRONTIERS IN PHYSIOLOGY (2018)
A causal link between oxidative stress and inflammation in cardiovascular and renal complications of diabetes
Jay C. Jha et al.
CLINICAL SCIENCE (2018)
Diabetes and Associated Cardiovascular Complications in American Indians/Alaskan Natives: A Review of Risks and Prevention Strategies
Anil Poudel et al.
JOURNAL OF DIABETES RESEARCH (2018)
Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Results From the LEADER Trial
Johannes F. E. Mann et al.
CIRCULATION (2018)
Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke Post Hoc Analysis From the LEADER Trial
Subodh Verma et al.
CIRCULATION (2018)
Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease
Guanghong Jia et al.
DIABETOLOGIA (2018)
Introduction to Special Issue Redox regulation of cardiovascular signaling in health and disease
Santiago Lamas et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Theo Vos et al.
LANCET (2017)
The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk
Marek Femlak et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential
Alyssa Faria et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Metformin Alleviates Altered Erythrocyte Redox Status During Aging in Rats
Geetika Garg et al.
REJUVENATION RESEARCH (2017)
Diabetic microangiopathy: Pathogenetic insights and novel therapeutic approaches
Rosalinda Madonna et al.
VASCULAR PHARMACOLOGY (2017)
The Metabolic Memory Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications
Roberto Testa et al.
NUTRIENTS (2017)
Nε-carboxymethyl-lysine promotes calcium deposition in VSMCs via intracellular oxidative stress-induced PDK4 activation and alters glucose metabolism
Wen-Qi Ma et al.
ONCOTARGET (2017)
Pyridoxamine improves survival and limits cardiac dysfunction after MI
Dorien Deluyker et al.
SCIENTIFIC REPORTS (2017)
Advanced glycation end products reduce the calcium transient in cardiomyocytes by increasing production of reactive oxygen species and nitric oxide
Zeinab Hegab et al.
FEBS OPEN BIO (2017)
Glucagon-like Peptide 1 Conjugated to Recombinant Human Serum Albumin Variants with Modified Neonatal Fc Receptor Binding Properties. Impact on Molecular Structure and Half-Life
Jens T. Bukrinski et al.
BIOCHEMISTRY (2017)
Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials
Matthew J. Levine
CURRENT DIABETES REVIEWS (2017)
Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes
Francesco Paneni et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
Interaction Between the Haptoglobin Genotype and Vitamin E on Cardiovascular Disease in Diabetes
Irit Hochberg et al.
CURRENT DIABETES REPORTS (2017)
Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells
Xiaomei Ren et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial
Tina Costacou et al.
ACTA DIABETOLOGICA (2016)
Uremic Toxicity of Advanced Glycation End Products in CKD
Andrea E. M. Stinghen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Oscillating glucose induces microRNA-185 and impairs an efficient antioxidant response in human endothelial cells
Lucia La Sala et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome
Hiroaki Kusaka et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Clinical Update: Cardiovascular Disease in Diabetes Mellitus Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations
Cecilia C. Low Wang et al.
CIRCULATION (2016)
Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes
Manasi S. Shah et al.
CIRCULATION RESEARCH (2016)
SGLT2 Inhibitors and Cardiovascular Risk: Lessons Learned From the EMPA-REG OUTCOME Study
Muhammad Abdul-Ghani et al.
DIABETES CARE (2016)
Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect
Mohamed Haddad et al.
DISEASE MARKERS (2016)
High plasma level of soluble RAGE is independently associated with a low recurrence of atrial fibrillation after catheter ablation in diabetic patient
Pil-Sung Yang et al.
EUROPACE (2016)
Enhanced nitric oxide generation from nitric oxide synthases as the cause of increased peroxynitrite formation during acute restraint stress: Effects on carotid responsiveness to angiotensinergic stimuli in type-1 diabetic rats
Josimar D. Moreira et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Targeting advanced glycation with pharmaceutical agents: where are we now?
Danielle J. Borg et al.
GLYCOCONJUGATE JOURNAL (2016)
Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications
Caroline Pereira Domingueti et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
Exercise Modulates Oxidative Stress and Inflammation in Aging and Cardiovascular Diseases
Nada Sallam et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Sulfur Dioxide Contributes to the Cardiac and Mitochondrial Dysfunction in Rats
Guohua Qin et al.
TOXICOLOGICAL SCIENCES (2016)
Restoration of Mitochondrial Cardiolipin Attenuates Cardiac Damage in Swine Renovascular Hypertension
Alfonso Eirin et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology
Olga Simo-Servat et al.
JOURNAL OF DIABETES RESEARCH (2016)
Effects of glucagon-like peptide-1 on advanced glycation endproduct-induced aortic endothelial dysfunction in streptozotocin-induced diabetic rats: possible roles of Rho kinase- and AMP kinase-mediated nuclear factor κB signaling pathways
Song-tao Tang et al.
ENDOCRINE (2016)
The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes
Breay W. Paty
Canadian Journal of Diabetes (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Jennifer B. Green et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Baicalein Attenuates Angiotensin II-Induced Cardiac Remodeling via Inhibition of AKT/mTOR, ERK1/2, NF-κB, and Calcineurin Signaling Pathways in Mice
Ai-Wu Wang et al.
AMERICAN JOURNAL OF HYPERTENSION (2015)
Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells
Mohamed I. Saad et al.
ENDOCRINE (2015)
Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes
Marcello C. Bertoluci et al.
WORLD JOURNAL OF DIABETES (2015)
Resveratrol-Dependent Down-regulation of Receptor for Advanced Glycation End-products and Oxidative Stress in Kidney of Rats With Diabetes
Heresh Moridi et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2015)
Baking, Ageing, Diabetes: A Short History of the Maillard Reaction
Michael Hellwig et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Rho/Rho-Associated Coiled-Coil Forming Kinase Pathway as Therapeutic Targets for Statins in Atherosclerosis
Naoki Sawada et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Is Rosiglitazone as Safe as BARI 2D and the Reanalysis of RECORD Imply?
James J. DiNicolantonio et al.
CARDIOLOGY (2014)
Skin aging by glycation: lessons from the reconstructed skin model
Herve Pageon et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
Adipose tissue mitochondrial dysfunction triggers a lipodystrophic syndrome with insulin resistance, hepatosteatosis, and cardiovascular complications
Cecile Vernochet et al.
FASEB JOURNAL (2014)
Fluvastatin-induced reduction of oxidative stress ameliorates diabetic cardiomyopathy in association with improving coronary microvasculature
Takuya Shida et al.
HEART AND VESSELS (2014)
Ovalbumin Modified with Pyrraline, a Maillard Reaction Product, shows Enhanced T-cell Immunogenicity
Monika Heilmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
S. Zoungas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Molecular mechanisms of AGE/RAGE-mediated fibrosis in the diabetic heart
Jia Zhao et al.
WORLD JOURNAL OF DIABETES (2014)
Usefulness of Preprocedural Levels of Advanced Glycation End Products to Predict Restenosis in Patients With Controlled Diabetes Mellitus Undergoing Drug-Eluting Stent Implantation for Stable Angina Pectoris (From the Prospective ARMYDA-AGEs Study)
Cristiano Spadaccio et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Insulin Resistance, Oxidative Stress and Cardiovascular Complications: Role of Sirtuins
Pankaj K. Bagul et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Redox signaling in cardiovascular health and disease
Nageswara R. Madamanchi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Studies on glycation of human low density lipoprotein: A functional insight into physico-chemical analysis
Saheem Ahmad et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2013)
Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases
Nitin Mahajan et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Inhibitory effect of soluble RAGE in disturbed flow-induced atherogenesis
Chang Hoon Ha et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: A glycoxidation-centric point of view
N. C. Chilelli et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2013)
被撤回的出版物: The Effect of Soluble RAGE on Inhibition of Angiotensin II-Mediated Atherosclerosis in Apolipoprotein E Deficient Mice (Retracted article. See vol. 9, e108684, 2014)
Dajeong Lee et al.
PLOS ONE (2013)
Adaptive Immunity, Inflammation, and Cardiovascular Complications in Type 1 and Type 2 Diabetes Mellitus
Daniela Pedicino et al.
JOURNAL OF DIABETES RESEARCH (2013)
Adiponectin abates diabetes-induced endothelial dysfunction by suppressing oxidative stress, adhesion molecules, and inflammation in type 2 diabetic mice
Sewon Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes
Sho-ichi Yamagishi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Impaired redox signaling and mitochondrial uncoupling contributes vascular inflammation and cardiac dysfunction in type 1 diabetes: Protective role of arjunolic acid
Prasenjit Manna et al.
BIOCHIMIE (2012)
Advanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36
Weifei Zhu et al.
BLOOD (2012)
Serum Levels of Advanced Glycation End Products (AGEs) are Inversely Associated with the Number and Migratory Activity of Circulating Endothelial Progenitor Cells in Apparently Healthy Subjects
So Ueda et al.
CARDIOVASCULAR THERAPEUTICS (2012)
Selective Divalent Copper Chelation for the Treatment of Diabetes Mellitus
G. J.S. Cooper
CURRENT MEDICINAL CHEMISTRY (2012)
Chelation: A Fundamental Mechanism of Action of AGE Inhibitors, AGE Breakers, and Other Inhibitors of Diabetes Complications
Ryoji Nagai et al.
DIABETES (2012)
Advanced glycation end-products induce injury to pancreatic beta cells through oxidative stress
N. Lin et al.
DIABETES & METABOLISM (2012)
Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes
K. Huynh et al.
DIABETOLOGIA (2012)
Crosstalk Between the Renin-Angiotensin System and the Advance Glycation End Product Axis in the Heart: Role of the Cardiac Fibroblast
Katrina Go Yamazaki et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2012)
Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis
Vasundhara Kain et al.
CARDIOVASCULAR DIABETOLOGY (2011)
Higher Plasma Levels of Advanced Glycation End Products Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes A 12-year follow-up study
Johanna W. Nin et al.
DIABETES CARE (2011)
Role of advanced glycation end product receptors in the pathogenesis of diabetic retinopathy
Hala O. Al-Mesallamy et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2011)
Advanced Glycation End Product Recognition by the Receptor for AGEs
Jing Xue et al.
STRUCTURE (2011)
Mitochondrial dysfunction in the type 2 diabetic heart is associated with alterations in spatially distinct mitochondrial proteomes
Erinne R. Dabkowski et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Impact of the Renin-Angiotensin-Aldosterone-System on Cardiovascular and Renal Complications in Diabetes Mellitus
Tetsuya Hayashi et al.
CURRENT VASCULAR PHARMACOLOGY (2010)
Deletion of the Receptor for Advanced Glycation End Products Reduces Glomerulosclerosis and Preserves Renal Function in the Diabetic OVE26 Mouse
Nina Reiniger et al.
DIABETES (2010)
Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype
Shany Blum et al.
PHARMACOGENOMICS (2010)
The multifaceted therapeutic potential of benfotiamine
Pitchai Balakumar et al.
PHARMACOLOGICAL RESEARCH (2010)
Glycaemic control and cardiovascular morbi-mortality: The contribution of the 2008 studies
C. Cugnet-Anceau et al.
ANNALES D ENDOCRINOLOGIE (2009)
Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction
Csaba Szabo
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Foxo1 Links Hyperglycemia to LDL Oxidation and Endothelial Nitric Oxide Synthase Dysfunction in Vascular Endothelial Cells
Jun Tanaka et al.
DIABETES (2009)
How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines
Ghazal Ansari et al.
ADVANCES IN THERAPY (2008)
Rosuvastatin protects against oxidative stress and DNA damage in vitro via upregulation of glutathione synthesis
Nicole Schupp et al.
ATHEROSCLEROSIS (2008)
Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients
Antonio Ceriello et al.
DIABETES (2008)
Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products:: evidence for the multiple-hit agent?
Katerina Kankova
PROCEEDINGS OF THE NUTRITION SOCIETY (2008)
Cost-utility analysis of intensive blood glucose control with metformin versus usual care in overweight type 2 diabetes mellitus patients in Beijing, P.R. China
Xuanqian Xie et al.
VALUE IN HEALTH (2008)
Mitochondrial pathophysiology, reactive oxygen species, and cardiovascular diseases
Ling Gao et al.
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2008)
LV systolic impairment in patients with asymptomatic coronary heart disease and type I diabetes is related to coronary atherosclerosis, glycaemic control and advanced glycation endproducts
Kjetil Steine et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors
Hikaru Sugimoto et al.
DIABETES (2007)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension
Susan J. Zieman et al.
JOURNAL OF HYPERTENSION (2007)
Evidence-based cardiovascular therapies and achievement of therapeutic goals in diabetic patients with coronary heart disease attended in primary care
Jose M. Mostaza-Prieto et al.
AMERICAN HEART JOURNAL (2006)
Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cβ -: Null mice
Yuzuru Ohshiro et al.
DIABETES (2006)
Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes
Fabio Fiordaliso et al.
LIFE SCIENCES (2006)
Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy:: effect of angiotensin-converting enzyme and vasopeptidase inhibition
C Wihler et al.
DIABETOLOGIA (2005)
Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-α -: Dependent pathway
V Thallas-Bonke et al.
DIABETES (2004)
The role of the renin-angiotensin-aidosterone system in diabetes and its vascular complications
ME Cooper
AMERICAN JOURNAL OF HYPERTENSION (2004)
Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB
ML Onozato et al.
KIDNEY INTERNATIONAL (2002)
Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes
I Idris et al.
DIABETOLOGIA (2001)
分享论文
